These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15025801)

  • 1. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for shared idiotypy expressed by the IgM, IgG, and IgA serum proteins of a patient with a complex multiple paraprotein disorder.
    Hopper JE; Haren JM; Kmiecik TE
    J Immunol; 1979 May; 122(5):2000-6. PubMed ID: 87449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of paraproteins by immunoturbidimetry and electrophoresis followed by scanning densitometry.
    Sinclair D; Ballantyne F; Shanley S; Caine E; O'Reilly D; Shenkin A
    Ann Clin Biochem; 1990 Jul; 27 ( Pt 4)():335-7. PubMed ID: 2119564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.
    Kubagawa H; Bertoli LF; Barton JC; Koopman WJ; Mestecky J; Cooper MD
    J Immunol; 1987 Jan; 138(2):435-9. PubMed ID: 3794339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohyperphosphataemia in patients with multiple myeloma.
    McClure D; Lai LC; Cornell C
    J Clin Pathol; 1992 Aug; 45(8):731-2. PubMed ID: 1401189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
    Sonnenblick M; Eylath U; Brisk R; Eldad C; Hershko C
    Clin Chem; 1986 Aug; 32(8):1537-9. PubMed ID: 3731447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal immunoglobulins and serum viscosity: contribution of the idea of activation energy to the paraprotein concept (author's transl)].
    Rovel A; Rovel B; Vigneron C; Streiff F
    Ann Biol Clin (Paris); 1979; 37(3):151-6. PubMed ID: 115345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of IgA2-lambda type M-protein that IgA concentration differs from the values of M-protein by serum protein electrophoresis].
    Fukushima M; Sugano M; Ichikawa T; Honda T; Totsuka M; Katsuyama T; Fujita K
    Rinsho Byori; 2001 Jul; 49(7):690-4. PubMed ID: 11519133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohyperphosphataemia in multiple myeloma.
    Hawkins RC
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():226-8. PubMed ID: 1872566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IgA, IgM, IgD and IgE in IgG paraproteinaemias.
    Tichý ; Hrncír Z; Simsa J
    Haematologia (Budap); 1977; 11(1-2):79-83. PubMed ID: 615091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraprotein interference causing pseudohyperphosphataemia: evaluation of an improved methodology.
    Savory DJ; Pearce CJ
    Ann Clin Biochem; 1995 Sep; 32 ( Pt 5)():498-501. PubMed ID: 8830626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method.
    Zaman Z; Sneyers L; Van Orshoven A; Blanckaert N; Mariën G
    Clin Chem; 1995 Apr; 41(4):609-14. PubMed ID: 7720254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohyperphosphatemia and dysproteinemia.
    Busse JC; Gelbard MA; Byrnes JJ; Hellman R; Vaamonde CA
    Arch Intern Med; 1987 Nov; 147(11):2045-6. PubMed ID: 3675108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement.
    Bowles SA; Tait RC; Jefferson SG; Gilleece MH; Haeney MR
    Ann Clin Biochem; 1994 May; 31 ( Pt 3)():249-54. PubMed ID: 8067665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G paraprotein cross-reactivity with immunoglobulin M measurement.
    Hawkins RC; Lee LK
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):431-3. PubMed ID: 18583633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
    Gore ME; Riches PG; Kohn J
    J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.